当前位置: 首页 >> 检索结果
1981. Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial.
作者: Mark R Nelson.;Galina Polekhina.;Robyn L Woods.;Christopher M Reid.;Andrew M Tonkin.;Rory Wolfe.;Anne M Murray.;Brenda Kirpach.;Michael E Ernst.;Jessica E Lockery.;Raj C Shah.;Nigel Stocks.;Suzanne G Orchard.;Zhen Zhou.
来源: Ann Intern Med. 2022年175卷5期761-764页 1983. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge : A Cross-Sectional Study.
作者: John Schrom.;Carina Marquez.;Genay Pilarowski.;Chung-Yu Wang.;Anthea Mitchell.;Robert Puccinelli.;Doug Black.;Susana Rojas.;Salustiano Ribeiro.;Valerie Tulier-Laiwa.;Jacqueline Martinez.;Joselin Payan.;Susy Rojas.;Diane Jones.;Daniel Martinez.;Robert Nakamura.;Gabriel Chamie.;Vivek Jain.;Maya Petersen.;Joe DeRisi.;Diane Havlir.
来源: Ann Intern Med. 2022年175卷5期682-690页
SARS-CoV-2 rapid antigen tests are an important public health tool.
1984. A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist.
作者: Yang Song.;Pablo Alonso-Coello.;Monica Ballesteros.;Francoise Cluzeau.;Robin W M Vernooij.;Thurayya Arayssi.;Soumyadeep Bhaumik.;Yaolong Chen.;Davina Ghersi.;Etienne V Langlois.;Paulina Fuentes Padilla.;Holger J Schünemann.;Elie A Akl.;Laura Martínez García.; .;Yasser Amer.;Ingrid Arevalo-Rodriguez.;Steven Barnes.;Jorge Barreto.;Deborah Collis.;Suzanne Dyer.;Christine Fahim.;Ivan Florez.;Veronica Gallegos-Rivero.;Miloslav Klugar.;Ton Kuijpers.;Joseph L Mathew.;Zachary Munn.;Sarah Norris.;Daniel F Patiño-Lugo.;C S Pramesh.;Jaime Rodriguez.;Sudipto Roy.;Ein-Soon Shin.;Ojino Sosa.;Per Olav Vandvik.;Marcela Velez.;Rachel Woodcraft.; .
来源: Ann Intern Med. 2022年175卷5期710-719页
Adaptation of existing guidelines can be an efficient way to develop contextualized recommendations. Transparent reporting of the adaptation approach can support the transparency and usability of the adapted guidelines.
1986. Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.
作者: Emma E McGinty.;Mark C Bicket.;Nicholas J Seewald.;Elizabeth A Stuart.;G Caleb Alexander.;Colleen L Barry.;Alexander D McCourt.;Lainie Rutkow.
来源: Ann Intern Med. 2022年175卷5期617-627页
There is concern that state laws to curb opioid prescribing may adversely affect patients with chronic noncancer pain, but the laws' effects are unclear because of challenges in disentangling multiple laws implemented around the same time.
1987. Toward Unbiased Evaluation of Postacute Sequelae of SARS-CoV-2 Infection: Challenges and Solutions for the Long Haul Ahead.
The authors argue that postacute SARS-CoV-2 syndrome presents unique challenges in determining risk factors, natural history, and proper management. They call for strategies and actions that are based on rigorous, high-quality evidence.
1991. Association Between Socioeconomic Disadvantage and Decline in Function, Cognition, and Mental Health After Critical Illness Among Older Adults : A Cohort Study.
作者: Snigdha Jain.;Terrence E Murphy.;John R O'Leary.;Linda Leo-Summers.;Lauren E Ferrante.
来源: Ann Intern Med. 2022年175卷5期644-655页
Older adults admitted to an intensive care unit (ICU) are at risk for developing impairments in function, cognition, and mental health. It is not known whether socioeconomically disadvantaged older persons are at greater risk for these impairments than their less vulnerable counterparts.
1992. Type 1 Diabetes Mellitus.
Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic β cells stop producing insulin, typically due to autoimmune destruction. This results in hyperglycemia and ketosis; thus, insulin replacement is vital to management. Incidence peaks in puberty and early adulthood, but onset can occur at any age. However, prevalence is highest among adults because persons with T1DM live for many years. Symptoms include polyuria, polydipsia, and weight loss. Acute complications include diabetic ketoacidosis, which requires urgent management. Long-term complications include microvascular and macrovascular disease. Patients with T1DM are at higher risk for other autoimmune diseases and psychosocial issues. Management should focus on optimizing glucose control to reduce acute and long-term complications.
1994. In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barré syndrome.
Goud R, Lufkin B, Duffy J, et al. Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries. JAMA Intern Med. 2021;181:1623-30. 34724025.
1995. DAPT de-escalation from ticagrelor to clopidogrel 1 mo after PCI for acute MI reduced net clinical events at 1 y.
Kim CJ, Park MW, Kim MC, et al. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial. Lancet. 2021;398:1305-16. 34627490.
1996. In COVID-19 with hypoxemia, 12 vs. 6 mg/d of dexamethasone did not increase days alive without life support.
Munch MW, Myatra SN, Vijayaraghavan BK, et al. Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial. JAMA. 2021;326:1807-17. 34673895.
1997. Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
作者: Catia Marzolini.;Daniel R Kuritzkes.;Fiona Marra.;Alison Boyle.;Sara Gibbons.;Charles Flexner.;Anton Pozniak.;Marta Boffito.;Laura Waters.;David Burger.;David Back.;Saye Khoo.
来源: Ann Intern Med. 2022年175卷5期744-746页
Nirmatrelvir–ritonavir (NMV/r) is now being used to treat high-risk patients with mild to moderate COVID-19. This article provides advice to clinicians regarding recognition of medications likely to interact with NMV/r and suggests approaches to managing such drug–drug interactions. An algorithm is provided to assist in decision making.
1998. Invitation to a single FS screening vs. usual care reduced colorectal cancer mortality and incidence at >15 y.
Senore C, Riggi E, Armaroli P, et al. Long-term follow-up of the Italian flexible sigmoidoscopy screening trial. Ann Intern Med. 2022;175:36-45. 34748376.
1999. In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortality.
Kanie T, Mizuno A, Takaoka Y, et al. Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis. Cochrane Database Syst Rev. 2021;10:CD013650. 34693515.
2000. In patients with MI or high-risk coronary disease, influenza vaccination reduced CV events at 12 mo.
Fröbert O, Götberg M, Erlinge D, et al. Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial. Circulation. 2021;144:1476-84. 34459211.
|